$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.

INFUSION TIME 3.NO BREAST CANCER ISSUES 4.

- Lowest ARR rate, no black box label, reduced brain lesions, and no reports of breast cancer.

Lowest ARR rate, no black box warning label, reduced brain lesions, and no reports of breast cancer (there are reports of breast cancer with other MS treatments, and 75% of people with MS are women).

$TGTX "4 Stories of Living with Multiple Sclerosis" Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.

No breast cancer risk.

Major upgrade for patients and infusion centers -No major health threats like breast cancer or sever liver damage like main competition

$TGTX possibly the best therapy available for MS patients that exists today!

MS is 3 times more common in women and there were no reports of breast cancer compared to the competition!

So brilliant to save people’s lives and stop cancer in its tracks.

$HTGM $THER Ther good buy with 1$ soon Theralink.com Tests available for cancers and rppa tech for treatments Ther stock symbol

$HTGM best tests on the market for cancer

Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.

$PBLA cheapest cancer therapy stock on the market, load-up!!

$HTGM MGTA BIG ONE POSITIVE GENE THERAPY

$SLRX “These initial data explain why we believe SP-3164 is so exciting, with the potential to make a positive difference in the treatment of hematologic cancers.

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)